NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 Diabetes Mellitus
Date of first enrollment	19/06/2014
Target sample size	70
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : TS-071 INN of investigational material : luseogliflozin Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	- Type 2 diabetes mellitus - Has been receiving treatment with GLP-1 receptor agonist monotherapy at a fixed dose within the limit of approved continuously for more than 8 weeks. etc.
Exclude criteria	- Having non-type 2 diabetes mellitus. - Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease. etc.